Sensex Finishes the Week on a Strong Note; HDFC, Sun Pharma Surge

Fri, 17 Feb Closing

   Previous Close   

   Pre-Open   

   09:30 am   

   11:30 am   

   01:30 pm   

Stock markets in India continued to trade on a positive note in the afternoon session and finished firm for fourth consecutive session. At the closing bell, the BSE Sensex stood higher by 167 points, while the NSE Nifty finished up by 44 points. Meanwhile, the S&P BSE Mid Cap and the S&P BSE Small Cap finished up by 0.5% and 0.4% respectively. Gains were largely seen in pharma stocks, oil & gas stocks and bank stocks.

HDFC Bank share price rose to an all-time high after the Reserve Bank of India removed the foreign institutional investor (FIIs) ban limit on the counter. However, HDFC Bank pared gains (finished up by 3.7%) in the afternoon session after the private sector lender crossed overall limit of 74% of its paid-up capital.

Asian stock markets finished lower today with shares in China leading the region. The Shanghai Composite is down 0.85% while Japan's Nikkei 225 is off 0.58% and Hong Kong's Hang Seng is lower by 0.31%. European markets are lower today with shares in France off the most. The CAC 40 is down 0.85% while Germany's DAX is off 0.35% and London's FTSE 100 is lower by 0.24%.

The rupee was trading at Rs 67.04 against the US$ in the afternoon session. Oil prices were trading at US$ 53.83 at the time of writing.

According to a leading financial daily, Bharti Airtel has completed the merger of Augere Wireless Broadband India (Augere), a wholly owned subsidiary with itself. Last year in August, the company had signed a definitive agreement to acquire 100% equity stake in Augere. The deal size is estimated to be around Rs 1.5 billion.

Augere is engaged in the business of operating, supplying, managing, dealing and using communication, telecommunication service, telecommunication system etc. as also carrying on the business in the field of providing broadband wireless service, internet service, telecommunication etc.

Augere holds 20 Mhz of spectrum in 2,300 Mhz band in Madhya Pradesh service area, which includes Chhattisgarh, to be used for 4G services. The company had won this spectrum for Rs 1.24 billion in 2010 but has not rolled out services.

Bharti Airtel share price finished the trading day up 0.9% on the BSE.

In another news, Idea Cellular share price plunged 5% before recovering and finished down by 1.7% after it was reported that the company will move out of National Stock Exchange's Nifty 50 index from March 31.

Moving on to news from stocks in pharma sector. Sun Pharmaceuticals share price surged and finished up by 4% in today's trade after it was reported that the company's subsidiary received approval for Tobramycin from the European Medicines Agency.

The approval for the product was received by company's wholly owned subsidiary firm from the European Medicines Agency. The company and its subsidiaries continue to file multiple products across multiple countries on an on-going basis.

Sun Pharma posted a net profit decline of 5% to Rs 14.71 billion in the third quarter ended December as compared to Rs 15.44 billion in the same period previous year.

Sales growth in main markets such as the US and India was slower than expected. Sun Pharma's US market sales in dollar terms rose by 4% over a year ago and declined by 9% sequentially. Growth was expected to suffer as the preceding quarter had one month of exclusivity-period sales of the generic version of cancer drug Gleevec.

Surprisingly, the India business growth at 5% year-on-year too was lower than expected. While notebandi was expected to hit sales growth, its portfolio tilt towards chronic categories would have protected it to an extent. Normalcy has still not returned and the trade's inability to hold inventory (due to the cash shortage) appears to have affected sales growth.

Demonetisation Effect: Defensive Sectors Corrected As Much As Smallcaps

In another development, Lupin share price too finished firm (up 1.2%) after the company received final US Food and Drug Administration (USFDA) approval for ANDA Moxifloxacin Hydrochloride Tablets, 400 mg, generic of Avlox Tablets of Bayer Healthcare Pharmaceuticals, Inc.

The company has recently received final approval for its Triamcinolone Acetonide Cream USP, 0.025%, 0.1% and 0.5% from the USFDA to market a generic equivalent of Mylan Pharmaceuticals Inc.'s.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers